Sugi Predict

Sugi Predict / Compounds / SCHEMBL93076

SCHEMBL93076

SCHEMBL93076

COc1cc(-c2ccc3c(n2)-c2ccccc2C3(C)C)ccc1-c1ccc(-c2ccc3c(n2)-c2ccccc2C3(C)C)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ PDK2 Q15119 1/20 0.39
▸ S1PR1 P21453 1/20 0.38
▸ ACACA Q13085 1/20 0.38
▸ HSD17B10 Q99714 5/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ HPGD P15428 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ USP2 O75604 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PDGFRB P09619 4/20 0.37
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81042 0.94 S1PR1 (0.43) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL80998 0.86 PDK2 (0.36) PDK2KMT2A
SCHEMBL81080 0.86 PDK2 (0.36) PDK2KMT2A
SCHEMBL80234 0.85 PDK2 (0.37) PDK2
SCHEMBL81005 0.85 PDK2 (0.37) PDK2
SCHEMBL80301 0.85 KMT2A (0.34) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL81600 0.84 PDK2 (0.35) PDK2KMT2A
SCHEMBL80817 0.84 KMT2A (0.33) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL82098 0.84 RARB (0.35) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL81002 0.84 PDK2 (0.33) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129899-B1 Azafluorene derivative and organic light-emitting device using the derivative CANON KABUSHIKI KAISHA (JP) 2012-03-06 — — US disclosed
US-20120049176-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2012-03-01 — — US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 — — US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 — — US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 — — US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE AZI2, CYP1A2, CYP2C19 KDM4E 852/4885ALDH1A1 21/4885NPC1 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.